Select another
Cluster

Luxembourg Cluster Portal

Luxembourg – an attractive location for research, development and innovation

Luxembourg BioHealth Cluster

The Luxembourg Government has identified the fast-growing Healthcare Biotech sector as a key innovation driver to foster economic diversification ...

Luxembourg EcoInnovation Cluster

Luxembourg hosts a thriving eco-innovation sector. There are numerous eco-companies in the country...

Luxembourg ICT Cluster

The Luxembourg ICT Cluster  is a network that supports the various actors in the field of ICT in Luxembourg with the goal of creating and developing new sustainable business opportunities.

Luxembourg Materials Cluster

Luxembourg’s strong track record in the manufacture and processing of many types of innovative materials is well proven with internationally renowned companies...

Luxembourg Space Cluster

The Luxembourg Space Cluster brings together renowned and highly specialised companies and public research organisations in order to develop specific technology topics... 

Luxembourg Cluster Portal Luxembourg BioHealth Cluster Luxembourg EcoInnovation Cluster Luxembourg ICT Cluster Luxembourg Materials Cluster Luxembourg Space Cluster
» Other Clusters:
Cluster for Logistics Luxembourg
Cluster Maritime Luxembourgeois
 

SafeSciMET course: Biomolecular analysis: From method development to clinical

Date: from 30-01-2012 to 03-02-2012

Address: BioMolecular Analysis Group Faculty of Sciences, VU University De Boelelaan 1083

ZIP: 1081 HV

City: Amsterdam

Country: Netherlands

This course is part of the programme developed under the Innovative Medicines Initiative, SafeSciMET, a public-private partnership between the European pharmaceutical industry (EFPIA) and European academia. All courses will have a mixed faculty of scientists from academia and industry and utilise case studies from industry. Courses are planned for the coming 2 years all over Europe.

The course will focus on Biomolecular analysis: From method development to clinical. It will cover the following themes:

  • Physico-chemical parameters at the basis of method development
  • Bioanalytical strategies for small molecules: sampling, sample pretreatment, separation, detection, validation and data handling.
  • General consideration in bioanalytical strategies for biopharmaceuticals
  • PK, PD, and biomarker assay formats
  • Development of immunogenic assay strategies: background, assay strategies, predictive immunogenicity
  • Integrated bioanalytical assay strategies
  • Novel developments: therapeutic oligonucleotides, reactive drug metabolites, profiling of body fluids and metabolomics

The courses can be taken individually. Fee per course is €2,500 – 750 (dependent on category of student) with discount schemes for multiple courses. The courses meets the criteria for Continuous Professional Development (CPD) diplomas and they will be part of a forthcoming European Master of Advanced Safety Science Degree.

Back to all events

More info

Course brochure

SafeSciMET course programme

Online course application